Twist Bioscience (TWST) Inventory Average (2018 - 2026)

Twist Bioscience (TWST) has reported Inventory Average for 9 consecutive years, with $33.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average rose 49.71% year-over-year to $33.2 million; the TTM figure through Mar 2026 stood at $33.2 million (up 49.71% YoY), while the FY2025 annual figure was $26.2 million, down 6.69% from the prior year.
• Inventory Average rose to $33.2 million in Q1 2026 per TWST's latest filing, from $30.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $43.8 million in Q2 2022 and bottomed at $22.2 million in Q1 2025.
• Historically, Inventory Average has averaged $33.1 million across 5 years, with a median of $31.5 million in 2023.
• Annual changes were most pronounced in 2022 — Inventory Average soared 190.05% — and 2024, when it dropped 27.54%.
• Twist Bioscience's Inventory Average stood at $42.0 million in 2022, then declined by 25.0% to $31.5 million in 2023, then declined by 24.36% to $23.8 million in 2024, then gained by 28.65% to $30.6 million in 2025, then advanced by 8.5% to $33.2 million in 2026.
• Business Quant data shows TWST's Inventory Average at $33.2 million in Q1 2026, $30.6 million in Q4 2025, and $27.1 million in Q3 2025.